NCT01254682

Intra-articular Hyaluronan Substitution in Arthroscopy of the Wrist

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 140 (actual)
• Sponsor: TRB Chemedica AG · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of this study is to evaluate the efficacy and safety of Ostenil application (1% hyaluronan) after arthroscopy of the wrist.

Conditions

• Arthroscopic Surgery

Interventions

Type	Name	Description
DEVICE	Ostenil	Standard arthroscopy (including intra-articular injection of 5 ml scandicain (0,5%), or 5 ml bupivacain plus 5 ml suprarenin in case of post-arthroscopic treatment). Add-on treatment with Ostenil after standard arthroscopic procedure. Application twice: first injection directly after arthroscopic procedure and second injection 3 weeks post arthroscopic.
PROCEDURE	Standard arthroscopic procedure	Standard arthroscopy (including intra-articular injection of 5 ml scandicain (0,5%), or 5 ml bupivacain plus 5 ml suprarenin in case of post-arthroscopic treatment) without add-on treatment.

Timeline

• Start date: 2007-01-01
• Primary completion: 2009-08-01
• Completion: 2009-08-01
• First posted: 2010-12-06
• Last updated: 2011-09-28

Locations

1 site across 1 country: Germany